Jason David Sawyer

CIK 2076325 · Chief Executive Officer · last filed 2026-07-23

Jason David Sawyer is a Chief Executive Officer who has filed 6 SEC Form 4 insider transactions across 4 companies since 2025. The most recent filing shows the insider bought $55.9K of KLTO on Jul 23, 2026. Across all open-market trades the lifetime net is +$55.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$2.08M

Companies

4

Total Filings

6

Lifetime Open-Market Net

$55.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Klotho Neurosciences, Inc. (KLTO) Delisted	Director	240,000	$0.52	$125.8K	$55.9K	1	2026-07-23
LIXT	Director	65,000	$7.21	$468.6K	$0	2	2026-07-02
GRDX	Chief Executive Officer	540,000	$2.99	$1.61M	$0	2	2026-07-01
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW) Delisted	Director	—	$0.02	—	$0	1	2025-08-18

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2026-07-23	Klotho Neurosciences, Inc. (KLTO) Delisted	Buy (P)	+240,000	$55.9K	EDGAR
2026-07-02	LIXT	Grant (A)	+40,000	$0	EDGAR
2026-07-01	GRDX	Grant (A)	+500,000	$0	EDGAR
2026-04-17	LIXT	Mixed	+25,000	$0	EDGAR
2025-12-29	GRDX	Grant (A)	+40,000	$0	EDGAR
2025-08-18	LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXTW) Delisted	Grant (A)	—	$0	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.